Matches in Nanopublications for { ?s ?p "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 18 of
18
with 100 items per page.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1126022.RAQzfilCDxaWu7ybNM0AINOKPjS8mZleY5mirUnYTO4f4130_assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126022.RAQzfilCDxaWu7ybNM0AINOKPjS8mZleY5mirUnYTO4f4130_provenance.
- NP1126019.RAAGLiRxyBN7yhEOF-lV0U9sD04_QRplW3gvQsQ8yaSI4130_assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126019.RAAGLiRxyBN7yhEOF-lV0U9sD04_QRplW3gvQsQ8yaSI4130_provenance.
- NP1126025.RAnU5NLkZSglZ-XlJjYkCOjrdKKSsHV8xq0pI0kk_NKRU130_assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126025.RAnU5NLkZSglZ-XlJjYkCOjrdKKSsHV8xq0pI0kk_NKRU130_provenance.
- NP1126020.RALKCGc08AfuwKRctrbdQ5Zb2rUxwv_aqb3pMw6cJk0Bg130_assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126020.RALKCGc08AfuwKRctrbdQ5Zb2rUxwv_aqb3pMw6cJk0Bg130_provenance.
- NP1126018.RA-dCQWEPCIYlCnvWkMioP7VQA-0CWA-w32im0dzgiqno130_assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126018.RA-dCQWEPCIYlCnvWkMioP7VQA-0CWA-w32im0dzgiqno130_provenance.
- NP1126021.RA3W_14kuRqJ-jlxptBi_wn81YKdAiSZNTEh-lA6DMjwc130_assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126021.RA3W_14kuRqJ-jlxptBi_wn81YKdAiSZNTEh-lA6DMjwc130_provenance.
- NP1126023.RA2cQ8hd6rPvBGJs6qSDtEnaHOTPVzeyn-LEqGPqNTtO0130_assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126023.RA2cQ8hd6rPvBGJs6qSDtEnaHOTPVzeyn-LEqGPqNTtO0130_provenance.
- NP1126024.RAyL5_YPai-j3QoYeuqaYlnzEeTjDd9g85Qjtv02xF7tk130_assertion description "[Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126024.RAyL5_YPai-j3QoYeuqaYlnzEeTjDd9g85Qjtv02xF7tk130_provenance.